MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, research has demonstrated that combining ADT with additional agents ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

The recommendation comes from a cooperative study involving 1205 men, said lead author Padraig Warde, MBChB, from the University of Toronto's Princess Margaret Hospital in Ontario. At 7 years, 74% of ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting ...

Prostatectomy and radiation therapy show no survival difference for low-risk prostate cancer, but higher-risk cases require careful treatment consideration. The ProtecT trial supports active ...

Read full article: MAD DADS announced its dissolution after 23 years of fighting against crime. A spokesman says the group is still active Read full article: Protect Pipes and Pets Amid Southeast Cold ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Joe Biden has completed a round of radiation therapy treatment for the aggressive form of prostate cancer he was diagnosed with after leaving office, his spokesperson informed. The 82-year-old former ...